Eliyahu Heldman
Executive Director
pharmaceutical
Youdim Pharmaceuticals
Israel
Biography
Prof. Eliyahu Heldman, A professor emeritus at Ben-Gurion University, with over 40 years’ experience in neuroscience research, Prof. Heldman’s experience includes work at NIH and evaluation of CNS-active drugs at the Israel Institute for Biological Research. In 2003, he co-founded NeuroDerm Ltd., Israel (NASDAQ: NDRM). Prof. Heldman was also a co-inventor of Cevimeline (EvoxacTM), an FDA-approved muscarinic agonist, for the treatment of Sjögren’s syndrome. He has published over 130 scientific articles, is co-inventor of more than 10 patents and has edited two books on the subject of neuroactive drugs.
Research Interest
Pharmaceutical science